Canada markets close in 28 minutes

Dechra Pharmaceuticals PLC (DPH.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
3,486.00-16.00 (-0.46%)
At close: 04:45PM BST
Currency in GBp

Valuation Measures4

Market Cap (intraday) 3.51B
Enterprise Value 3.70B
Trailing P/E 48.38
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.51
Price/Book (mrq)5.49
Enterprise Value/Revenue 5.78
Enterprise Value/EBITDA 31.56

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-19.53%
S&P500 52-Week Change 3-9.13%
52 Week High 35,525.00
52 Week Low 331.08
50-Day Moving Average 33,388.19
200-Day Moving Average 34,285.26

Share Statistics

Avg Vol (3 month) 3371.63k
Avg Vol (10 day) 3344.73k
Shares Outstanding 5108.39M
Implied Shares Outstanding 6N/A
Float 8107.75M
% Held by Insiders 11.46%
% Held by Institutions 168.78%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.41
Forward Annual Dividend Yield 41.31%
Trailing Annual Dividend Rate 30.41
Trailing Annual Dividend Yield 30.01%
5 Year Average Dividend Yield 40.99
Payout Ratio 460.47%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 03, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jun 30, 2021
Most Recent Quarter (mrq)Dec 31, 2021

Profitability

Profit Margin 11.38%
Operating Margin (ttm)16.25%

Management Effectiveness

Return on Assets (ttm)5.46%
Return on Equity (ttm)11.53%

Income Statement

Revenue (ttm)640.6M
Revenue Per Share (ttm)5.92
Quarterly Revenue Growth (yoy)10.90%
Gross Profit (ttm)345.9M
EBITDA 140.1M
Net Income Avi to Common (ttm)72.9M
Diluted EPS (ttm)67.00
Quarterly Earnings Growth (yoy)74.70%

Balance Sheet

Total Cash (mrq)123.7M
Total Cash Per Share (mrq)1.14
Total Debt (mrq)316.8M
Total Debt/Equity (mrq)49.57
Current Ratio (mrq)2.91
Book Value Per Share (mrq)5.90

Cash Flow Statement

Operating Cash Flow (ttm)119.1M
Levered Free Cash Flow (ttm)60.89M